Stark Law and Anti-Kickback in Wound Care Arrangements

Stark Law and Anti-Kickback: What Wound Care Providers Must Know

Stark Law and Anti-Kickback compliance is a daily concern for wound care providers, not a once-a-year legal review. Every referral relationship, supply arrangement, and service agreement in wound care touches one or both of these federal statutes. The penalties for violations are severe — treble damages under the False Claims Act, exclusion from Medicare, and criminal prosecution under the Anti-Kickback Statute. Understanding how these laws apply to the specific business arrangements common in wound care is essential for any provider who bills federal healthcare programs.

Wound care operates in a referral-heavy environment. Patients come from primary care physicians, skilled nursing facilities, home health agencies, and hospital discharge planners. Wound care providers purchase biological skin substitutes, advanced dressings, and negative pressure wound therapy equipment from manufacturers and distributors. Each of these relationships creates potential Stark Law and Anti-Kickback exposure.

How Stark Law Applies to Wound Care

The Stark Law (42 U.S.C. § 1395nn) prohibits a physician from referring Medicare patients for designated health services to an entity with which the physician or an immediate family member has a financial relationship, unless an exception applies. Wound care services frequently qualify as designated health services, particularly when they involve clinical laboratory services, outpatient prescription drugs, or DME.

Common Stark Law Scenarios in Wound Care

Physician-owned wound care centers. When a referring physician has an ownership interest in a wound care center, every referral to that center is a potential Stark violation unless it fits within an exception such as the in-office ancillary services exception or the bona fide employment exception.

Compensation arrangements with SNFs. A wound care physician who provides services at a skilled nursing facility and receives compensation that varies based on the volume or value of referrals from that facility has a Stark problem. Medical director agreements, in particular, must be structured at fair market value for actual services rendered, not as a mechanism to secure patient referrals.

Product-related financial relationships. If a wound care provider receives anything of value from a skin substitute manufacturer — consulting fees, speaker honoraria, research funding — and then orders that manufacturer's product for Medicare patients, the arrangement must satisfy a Stark exception.

Key Stark Exceptions for Wound Care

Fair market value exception — compensation must reflect the fair market value of the actual services provided, determined without regard to the volume or value of referrals
Personal services exception — requires a written agreement covering all services, signed by both parties, for a term of at least one year, with compensation that is set in advance and does not vary with referrals
In-office ancillary services exception — allows referrals for services performed within the same building where the referring physician practices, subject to specific supervision and billing requirements

How the Anti-Kickback Statute Applies to Wound Care

The Anti-Kickback Statute (42 U.S.C. § 1320a-7b) is broader than Stark. It prohibits offering, paying, soliciting, or receiving anything of value to induce or reward referrals for services covered by federal healthcare programs. Unlike Stark, the Anti-Kickback Statute applies to all providers, not just physicians, and it covers all federal healthcare program services, not just designated health services.

Common Anti-Kickback Risk Areas in Wound Care

Skin substitute manufacturer arrangements. Manufacturers of biological skin substitutes have significant financial incentive to increase product utilization. Arrangements where a manufacturer provides free samples, volume-based rebates, educational grants tied to product use, or consulting fees to high-volume prescribers all carry Anti-Kickback risk.

Referral source compensation. Paying a skilled nursing facility, home health agency, or physician practice for patient referrals — whether characterized as a "marketing fee," "case management fee," or "administrative services fee" — violates the Anti-Kickback Statute if one purpose of the payment is to induce referrals.

Free services to referral sources. Providing free wound care consultations, free clinical education, or free EMR access to facilities that refer patients creates Anti-Kickback exposure if the free services are provided to induce referrals rather than for legitimate, independent business purposes.

Transportation arrangements. Providing free transportation for wound care patients, while seemingly a patient benefit, can violate the Anti-Kickback Statute if the transportation is designed to steer patients to a particular provider. Limited exceptions exist for local transportation that meets specific criteria. For more on structuring compliant wound care operations, see the wound care compliance program guide.

Safe Harbors That Protect Wound Care Arrangements

Safe harbors provide legal protection for arrangements that technically could violate the Anti-Kickback Statute but serve legitimate business purposes:

Personal services and management contracts — written agreement, signed by parties, specifying services, for a term of at least one year, at fair market value, commercially reasonable apart from referrals
Employee safe harbor — payments to bona fide employees for employment services
Discount safe harbor — properly disclosed and accurately reported price reductions on products or services
Group purchasing organization safe harbor — fees paid by vendors to GPOs, subject to specific requirements

Fair Market Value: The Central Compliance Concept

Fair market value is the single most important compliance concept for wound care arrangements. Both Stark exceptions and Anti-Kickback safe harbors require that compensation reflect fair market value — the price that would be agreed upon by a willing buyer and a willing seller, neither under compulsion, with reasonable knowledge of relevant facts.

Establishing Fair Market Value in Wound Care

Medical director agreements — base compensation on documented hours at a rate consistent with published physician compensation surveys for wound care specialists
Consulting agreements — document the specific deliverables, verify the hours reported, and benchmark the hourly rate against comparable consulting arrangements
Supply arrangements — compare pricing against market rates from multiple vendors, document the comparison, and do not accept pricing that is below market as potential inducement

Red Flags That Suggest Fair Market Value Problems

Compensation that increases when referral volume increases
Payment for services that are vaguely defined or difficult to verify
Compensation significantly above published benchmarks without documented justification
Arrangements where the only plausible explanation for the payment is to secure referrals

Common Violations in Wound Care

The OIG and DOJ have pursued enforcement actions involving wound care arrangements that include:

Per-wound or per-patient fees paid to facilities for access to their patient population
Free product provided by manufacturers in exchange for exclusive purchasing commitments tied to Medicare volume
Sham consulting agreements where physicians receive payment for minimal work, with the real purpose being to reward referrals
Joint venture arrangements structured to share profits from Medicare wound care services with referral sources who contribute little beyond their referral stream

For more on how these arrangements intersect with facility partnerships, see the wound care SNF partnership model guide.

Key Takeaways

Every wound care referral relationship, supply arrangement, and service agreement must be evaluated against both Stark Law and the Anti-Kickback Statute — they are separate laws with overlapping but distinct requirements
Fair market value is the central compliance concept; compensation that varies with referral volume is the clearest red flag for both statutes
Skin substitute manufacturer arrangements are a high-risk area where volume-based rebates, free samples tied to utilization, and sham consulting agreements frequently violate the Anti-Kickback Statute
Written agreements with specific terms, fair market value compensation, and legitimate business purposes are required to satisfy both Stark exceptions and Anti-Kickback safe harbors
Enforcement actions in wound care consistently target per-wound fees to referral sources, manufacturer inducements, and medical director agreements that exceed fair market value